← Back
Data updated: Mar 10, 2026
POLAREAN
Respiratory
POLAREAN is a pharmaceutical company focused on Respiratory. Key products include XENOVIEW.
2022
Since
1
Drugs
-
Trials
1
Approved (2yr)
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Respiratory 100%
0 drugs Phase 3: 2
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2022-12-23
- Latest
- 2025-05-30
- Applications
- 1